Cargando…
Prophylaxis of migraine
Migraine is a common primary headache disorder often associated with significant disability. While many individuals are able to limit therapy to acute treatment of attacks, others need medication to reduce the attack frequency and/or severity. Evidence-based guidelines exist regarding indications an...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671824/ https://www.ncbi.nlm.nih.gov/pubmed/19412475 |
_version_ | 1782166434870198272 |
---|---|
author | Garza, Ivan Swanson, Jerry W |
author_facet | Garza, Ivan Swanson, Jerry W |
author_sort | Garza, Ivan |
collection | PubMed |
description | Migraine is a common primary headache disorder often associated with significant disability. While many individuals are able to limit therapy to acute treatment of attacks, others need medication to reduce the attack frequency and/or severity. Evidence-based guidelines exist regarding indications and goals for migraine preventive treatment. The specific prophylactic approach needs to be individualized taking into account multiple variables. Medications used in this task vary widely in proven efficacy and presumed mechanisms of action. This review’s goal is to discuss the issues that guide the decision-making process in migraine preventive treatment. |
format | Text |
id | pubmed-2671824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26718242009-04-30 Prophylaxis of migraine Garza, Ivan Swanson, Jerry W Neuropsychiatr Dis Treat Expert Opinions and Reviews Migraine is a common primary headache disorder often associated with significant disability. While many individuals are able to limit therapy to acute treatment of attacks, others need medication to reduce the attack frequency and/or severity. Evidence-based guidelines exist regarding indications and goals for migraine preventive treatment. The specific prophylactic approach needs to be individualized taking into account multiple variables. Medications used in this task vary widely in proven efficacy and presumed mechanisms of action. This review’s goal is to discuss the issues that guide the decision-making process in migraine preventive treatment. Dove Medical Press 2006-09 /pmc/articles/PMC2671824/ /pubmed/19412475 Text en © 2006 Dove Medical Press Limited. All rights reserved |
spellingShingle | Expert Opinions and Reviews Garza, Ivan Swanson, Jerry W Prophylaxis of migraine |
title | Prophylaxis of migraine |
title_full | Prophylaxis of migraine |
title_fullStr | Prophylaxis of migraine |
title_full_unstemmed | Prophylaxis of migraine |
title_short | Prophylaxis of migraine |
title_sort | prophylaxis of migraine |
topic | Expert Opinions and Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671824/ https://www.ncbi.nlm.nih.gov/pubmed/19412475 |
work_keys_str_mv | AT garzaivan prophylaxisofmigraine AT swansonjerryw prophylaxisofmigraine |